DNAJA1 and cancer: We identified that plumbagin derivatives bound to DNAJA1 in cells and reduced the levels of DNAJA1 and other HSP40/JDPs, leading to decreased protein levels of multiple conformational mutp53 and reduced cancer cell migration in a manner dependent on DNAJA1 and mutp53.